Tumor hypoxia can induce HIF1, which post-transcriptionally inhibits the expression of miR-16-5p and promotes the expression of YTHDF1, which sequentially enhances tumor glycolysis via the up-regulation of PKM2, ultimately increasing the tumorigenic and metastatic potential of breast cancer cells [35]. Here, PKM is linked to breast cancer.